Porto Biomedical Journal

What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review

Porto Biomedical Journal 2021 Henrique Castro Santos, João Gama Marques 37 citations

Abstract Background: Psilocybin is a predominant agonist of 5HT 1A and 5HT 2A/C receptors and was first isolated in 1958, shortly before it became a controlled substance. Research on the potential therapeutic effects of this compound has recently re-emerged alongside what is being addressed as a psychedelic renaissance. Methods: In this paper we performed a systematic review of the clinical...